Media training for pharma and biotech is specialized coaching that prepares executives for pricing questions, FDA milestones, and clinical data coverage. Drug pricing, FDA approvals, clinical trial data, and patient access are daily news topics. When a reporter calls, the story is already framed. Jess trains pharma and biotech leaders to walk into those conversations with clarity, confidence, and a message that lands.
No industry faces more sustained public and media scrutiny than pharmaceutical and biotech companies. Pricing controversies, breakthrough therapy announcements, clinical trial results, and safety recalls all carry enormous reputational stakes. Your executives must be able to speak fluently to journalists, investors, regulators, and patients, often with the same message, in the same interview.
No story attracts more aggressive questioning than drug costs. Your executives need answers that are honest, defensible, and don't create new headlines.
Approval day generates a wave of media interest. Spokespeople must communicate efficacy, safety, and access plans without over-promising or triggering regulatory concerns.
Journalists and investors scrutinize trial data for spin. Your scientific leaders must explain results in plain language while maintaining complete scientific integrity.
A safety update or voluntary recall is a pivotal moment. How you communicate in the first 24 hours determines how the story resolves, and how much trust survives.
Develop honest, clear language around drug economics that acknowledges cost concerns while explaining value and investment in research.
Turn complex clinical data, biomarker results, and trial endpoints into accessible narratives without losing accuracy.
Respond to safety signals, recalls, and adverse event coverage with a message that demonstrates accountability and patient focus.
Communicate pipeline milestones, approval timelines, and commercial strategy in ways that build long-term investor and analyst trust.
"This whole session was extremely helpful. I needed to work in all areas... I really can see my improvement on-screen. This will help me tremendously professionally."
Yes. Pricing is the most aggressive line of questioning in pharma, so it gets dedicated practice. Executives rehearse honest, defensible answers in recorded exercises with hostile follow-ups, learning to acknowledge patient cost concerns while explaining value and access programs without producing a damaging sound bite.
Yes. Sessions are built around regulatory reality. Practice scenarios use approved or sanitized material, and Jess coordinates with your legal, regulatory, and investor relations teams so nothing rehearsed creates off-label, promotional, or disclosure exposure. Spokespeople learn to bridge away from restricted topics gracefully.
Media training typically ranges from $1,000 to $15,000 per engagement depending on group size and scope. A focused session for one spokesperson sits at the lower end, while multi-day team workshops with recorded practice sit higher. See our media training questions page for a full breakdown of what drives pricing.
Every session is led by Jess Todtfeld, founder of Success in Media. Jess spent 13 years as a television producer at NBC, ABC, and Fox, and holds the Guinness World Record for the most media interviews given in 24 hours: 112. He has trained pharmaceutical and biotech leaders to handle the industry's toughest questioning.
Jess works with life sciences executives to ensure they can walk into any media situation, approval announcements, crisis moments, investor calls, with a message that holds up under pressure.
Get a Quick QuotePrefer to talk it through first? Speak with Jess